Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eye Drops Study for Myopia Control in Schoolchildren
NCT03402100Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Oct 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised trial of NVK002 and ketorolac tromethamine in myopia (5 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoints: Cycloplegic spherical refraction change at 1 year and Axial length change at 1 year. Status: unknown.
02
Drugs
NVK002ketorolac tromethamine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT03402100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03402100.